DELTA & PINE LAND CO
10-Q, 2000-04-14
AGRICULTURAL PRODUCTION-CROPS
Previous: SAF T LOK INC, 10KSB, 2000-04-14
Next: UNAPIX ENTERTAINMENT INC, 10-K, 2000-04-14




                                  UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-Q

(x)  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934 For the quarterly period ended February 29, 2000 or

(    )  Transition  Report  Pursuant  to Section  13 or 15(d) of the  Securities
     Exchange  Act of 1934  For  the  transition  period  from  ____________  to
     _______________


                        Commission File Number: 000-21788

              Exact name of registrant as specified in its charter:

                           DELTA AND PINE LAND COMPANY

                        State of Incorporation: Delaware
                I.R.S. Employer Identification Number: 62-1040440

           Address of Principal Executive Offices (including zip code)
                    One Cotton Row, Scott, Mississippi 38772

               Registrant's telephone number, including area code:
                                 (662) 742-4500


Indicate by check mark whether  Registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports)  and  (2)  has  been  subject  to such  filing
requirements for the past 90 days.

YES (x) NO ( )

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

Common Stock,  $0.10 Par Value - 38,385,837  shares  outstanding as of March 30,
2000.


<PAGE>




                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES

                                      INDEX

 PART I.  FINANCIAL INFORMATION                                         Page No.

Item 1. Consolidated Financial Statements

Consolidated Balance Sheets - February 29, 2000,
     August 31, 1999, and February 28, 1999                                    2

Consolidated Statements of Operations - Three Months

     Ended February 28, 1999 and February 29, 2000                             3

Consolidated Statements of Operations - Six Months

     Ended February 28, 1999 and February 29, 2000                             4

Consolidated Statements of Cash Flows - Six Months

     Ended February 28, 1999 and February 29, 2000                             5

     Notes to Consolidated Financial Statements                                6

Item 2. Management's Discussion and Analysis of Financial
           Condition and Results of Operations                                13

PART II.  OTHER INFORMATION
     Item 1.   Legal Proceedings                                              17
     Item 4.   Submission of Matters to a Vote of Security Holders            17
     Item 5.   Business                                                       17
     Item 6.   Exhibits and Reports on Form 8-K                               23
                   Signatures                                                 24












<PAGE>


PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
<TABLE>
<CAPTION>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
               (in thousands, except share and per share amounts)
                                   (Unaudited)
                                                                                  February 28,      August 31,         February 29,
                                                                                      1999             1999               2000
                                                                                      ----             ----               ----
<S>                                                                                    <C>              <C>                <C>
ASSETS
CURRENT ASSETS:
     Cash and cash equivalents                                                    $   9,203         $   7,552            17,345
     Receivables, net                                                                90,836           147,926           127,614
     Inventories                                                                    106,874            47,727            74,118
     Prepaid expenses                                                                 4,604             1,473             1,673
     Income tax receivable                                                            2,481                 -                 -
     Deferred income taxes                                                            4,408            12,865            12,865
                                                                              --------------    --------------    --------------
         Total current assets                                                       218,406           217,543           233,615
                                                                              --------------    --------------    --------------

PROPERTY, PLANT and EQUIPMENT, net                                                   65,772            65,166            64,644

EXCESS OF COST OVER NET ASSETS OF
     BUSINESS ACQUIRED, net                                                           4,523             4,458             4,647

INTANGIBLES, net                                                                      3,495             4,365             4,401

OTHER ASSETS                                                                          2,128             4,226             3,095
                                                                              --------------    --------------    --------------
                                                                                  $ 294,324         $ 295,758           310,402
                                                                              ==============    ==============    ==============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
     Notes payable                                                                 $ 45,208         $   3,819               663
     Accounts payable                                                                29,925            19,990            33,315
     Accrued expenses                                                                76,573           143,352            94,124
     Income taxes payable                                                                 -             8,082            35,227
                                                                              --------------    --------------    --------------
         Total current liabilities                                                  151,706           175,243           163,329
                                                                              --------------    --------------    --------------
LONG-TERM DEBT, less current maturities                                              55,898            17,000                 0
                                                                              --------------    --------------    --------------
DEFERRED INCOME TAXES                                                                 5,020             5,773             5,773
                                                                              --------------    --------------    --------------
MINORITY INTEREST IN SUBSIDIARIES                                                     5,152             8,338             8,825
                                                                              --------------    --------------    --------------
STOCKHOLDERS' EQUITY:
  Preferred  stock,  par value  $0.10 per share;  2,000,000  shares authorized:
  Series A  Junior Participating Preferred, par value $0.10 per share;
  429,319 shares authorized; no shares issued or outstanding                            -                 -                 -
  Series M Convertible Non-Voting Preferred, par value $0.10 per share;
  1,066,667 shares authorized; 1,066,667, 1,066,667 and 1,066,667                     107               107               107
  shares issued and outstanding
  Common stock, par value $0.10 per share; 100,000,000 shares authorized;
  38,551,634; 38,664,565 and 38,843,547 shares issued; 38,437,368;
  38,550,299 and 38,376,781 shares outstanding                                        3,855             3,866             3,884
 Capital in excess of par value                                                      37,432            41,179            43,718
 Retained earnings                                                                   39,752            48,970            95,710
 Accumulated other comprehensive loss                                                (2,425)           (2,545)           (2,850)
 Treasury stock at cost, 114,266; 114,266 and 466,766 shares                         (2,173)           (2,173)           (8,094)
                                                                              --------------    --------------    --------------
         Total stockholders' equity                                                  76,548            89,404           132,475
                                                                              --------------    --------------    --------------
                                                                                  $ 294,324         $ 295,758           310,402
                                                                              ==============    ==============    ==============
</TABLE>

The accompanying notes are an integral part of these balance sheets.


<PAGE>
<TABLE>
<CAPTION>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                           FOR THE THREE MONTHS ENDED
                    (in thousands, except per share amounts)
                                   (Unaudited)

                                                                                  February 28,               February 29,
                                                                                        1999                       2000
                                                                             ---------------            ---------------
<S>                                                                                     <C>                        <C>
NET SALES AND LICENSING FEES                                                 $        72,800            $       104,203
COST OF SALES                                                                         49,684                     73,162
                                                                             ---------------            ---------------
GROSS PROFIT                                                                          23,116                     31,041
                                                                             ---------------            ---------------
OPERATING EXPENSES:
     Research and development                                                          4,880                      5,022
     Selling                                                                           3,848                      3,596
     General and administrative                                                        3,094                      2,985
                                                                             ---------------            ---------------
                                                                                      11,822                     11,603
                                                                             ---------------            ---------------
SPECIAL CHARGES AND UNUSUAL (INCOME) ITEM                                              6,125                   (74,694)
                                                                             ---------------            ---------------
OPERATING  INCOME                                                                      5,169                     94,132
INTEREST EXPENSE, net of capitalized interest of $12 and $21                          (1,093)                      (271)
OTHER                                                                                    478                         (4)
MINORITY INTEREST IN EARNINGS OF SUBSIDIARIES                                           (276)                        43
                                                                             ---------------            ---------------
INCOME BEFORE INCOME TAXES AND CUMULATIVE EFFECT OF
         ACCOUNTING CHANGE                                                             4,278                     93,900
INCOME TAX PROVISION                                                                   1,872                     35,265
                                                                             ---------------            ---------------
NET INCOME BEFORE CUMULATIVE EFFECT OF ACCOUNTING CHANGE                               2,406                     58,635
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING FOR
        STARTUP COSTS, NET                                                                 -                          -
                                                                             ---------------            ---------------
NET INCOME                                                                             2,406                     58,635

DIVIDENDS ON PREFERRED STOCK                                                             (24)                       (40)
                                                                             ---------------            ---------------
NET INCOME APPLICABLE TO COMMON SHARES                                       $         2,382            $        58,595
                                                                             ===============            ===============
BASIC EARNINGS PER SHARE:

NET INCOME PER SHARE BEFORE CUMULATIVE EFFECT OF
                ACCOUNTING CHANGE                                            $          .06             $          1.52

CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                                    -                           -
                                                                             --------------             ---------------
NET INCOME                                                                   $          .06             $          1.52
                                                                             ==============             ===============
NUMBER OF SHARES USED IN BASIC EARNINGS
     PER SHARE CALCULATIONS                                                          38,422                      38,644
                                                                             ==============             ===============
DILUTED EARNINGS PER SHARE:

NET INCOME PER SHARE BEFORE CUMULATIVE EFFECT OF
                ACCOUNTING CHANGE                                            $          .06             $          1.46

CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                                   -                            -
                                                                             --------------             ---------------
NET INCOME                                                                   $          .06             $          1.46
                                                                             ==============             ===============
NUMBER OF SHARES USED IN DILUTED EARNINGS
     PER SHARE CALCULATIONS                                                          40,819                      40,110
                                                                             ==============             ===============
DIVIDENDS PER COMMON SHARE                                                   $         0.03             $          0.03
                                                                             ==============             ===============
</TABLE>

The accompanying notes are an integral part of these statements.

<PAGE>

<TABLE>
<CAPTION>
                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                            FOR THE SIX MONTHS ENDED
                    (in thousands, except per share amounts)
                                   (Unaudited)

                                                                                February 28,               February 29,
                                                                                        1999                       2000
                                                                             ---------------              -------------
<S>                                                                                     <C>                          <C>
NET SALES AND LICENSING FEES                                                 $        79,996              $     108,751
COST OF SALES                                                                         54,552                     77,410
                                                                             ---------------              -------------
GROSS PROFIT                                                                          25,444                     31,341
                                                                             ---------------              -------------
OPERATING EXPENSES:
     Research and development                                                          9,115                      9,381
     Selling                                                                           7,678                      6,833
     General and administrative                                                        6,053                      6,069
                                                                             ---------------              -------------
                                                                                      22,846                     22,283
                                                                             ---------------              -------------
SPECIAL CHARGES AND UNUSUAL (INCOME) ITEM                                              7,022                    (74,227)
                                                                             ---------------              -------------
OPERATING  INCOME/(LOSS)                                                              (4,424)                    83,285
INTEREST EXPENSE, net of capitalized interest of $44 and $36                          (1,624)                      (188)
OTHER                                                                                     (9)                        78
MINORITY INTEREST IN EARNINGS OF SUBSIDIARIES                                            (26)                       159
                                                                             ---------------              -------------
INCOME/(LOSS)  BEFORE INCOME TAXES AND CUMULATIVE EFFECT OF
         ACCOUNTING CHANGE                                                            (6,083)                    83,334
INCOME TAX PROVISION/(BENEFIT)                                                        (2,051)                    31,250
                                                                             ---------------              -------------
NET INCOME BEFORE CUMULATIVE EFFECT OF ACCOUNTING CHANGE                              (4,032)                    52,084
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING FOR
        STARTUP COSTS, NET                                                                 -                     (2,965)
                                                                             ---------------              -------------
NET INCOME/(LOSS)                                                                     (4,032)                    49,119

DIVIDENDS ON PREFERRED STOCK                                                             (48)                       (64)
                                                                             ---------------              -------------
NET INCOME APPLICABLE TO COMMON SHARES                                       $         4,080              $      49,055
                                                                             ===============              ==============
BASIC EARNINGS PER SHARE:

NET INCOME/(LOSS) PER SHARE BEFORE CUMULATIVE EFFECT OF
                ACCOUNTING CHANGE                                            $        (0.11)              $         1.35

CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                                    -                        (0.08)
                                                                             --------------               --------------
NET INCOME/(LOSS)                                                            $        (0.11)              $         1.27
                                                                             ===============              ==============
NUMBER OF SHARES USED IN BASIC EARNINGS
     PER SHARE CALCULATIONS                                                           38,397                      38,653
                                                                             ===============              ==============
DILUTED EARNINGS PER SHARE:

NET INCOME/(LOSS) PER SHARE BEFORE CUMULATIVE EFFECT OF
                ACCOUNTING CHANGE                                            $        (0.11)              $         1.29

CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                                    -                        (0.07)
                                                                             --------------               --------------
NET INCOME/(LOSS)                                                            $        (0.11)              $         1.22
                                                                             ===============              ==============
NUMBER OF SHARES USED IN DILUTED EARNINGS
     PER SHARE CALCULATIONS                                                          38,397                       40,186
                                                                             ==============               ==============

DIVIDENDS PER COMMON SHARE                                                   $         0.06               $         0.06
                                                                             ==============               ===============
</TABLE>


The accompanying notes are an integral part of these statements.

<PAGE>
<TABLE>
<CAPTION>
                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                            FOR THE SIX MONTHS ENDED
                                 (in thousands)
                                   (Unaudited)

                                                                                     February 28,          February 29,
                                                                                          1999                    2000
                                                                                    ------------             ----------
<S>                                                                                          <C>                     <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                                                            $    (4,032)             $   49,119
Adjustments to reconcile net loss to net cash provided by
   (used in) operating activities:
     Depreciation and amortization                                                        3,288                   3,527
     Loss on sale of equipment                                                                0                      57
     Minority interest in earnings of subsidiaries                                           26                   (159)
     Non-cash items associated with unusual charges                                       2,863                       -
Changes in current assets and liabilities:
     Receivables                                                                         13,943                  20,312
     Inventories                                                                        (56,377)                (26,391)
     Prepaid expenses                                                                    (3,410)                   (200)
     Accounts payable                                                                     7,094                  13,325
     Accrued expenses                                                                   (15,469)                (46,025)
     Income taxes payable                                                                 3,081                  27,145
Decrease in intangible and other assets                                                     243                     852
                                                                                    -----------              ----------
         Net cash used in operating activities                                          (48,750)                 41,562
                                                                                    -----------              ----------
CASH FLOWS FROM INVESTING ACTIVITIES:
   Purchases of property and equipment                                                   (5,023)                 (3,008)
   Proceeds from sale of investment                                                           -                       -
                                                                                    -----------              ----------
         Net cash used in investing activities                                           (5,023)                 (3,008)
                                                                                    -----------              ----------
CASH FLOWS FROM FINANCING ACTIVITIES:
   Payments of short-term debt                                                          (12,255)                 (3,156)
   Payments of long-term debt                                                              (182)                (65,028)
   Dividends paid                                                                        (2,325)                 (2,379)
   Proceeds from long-term debt                                                           9,010                  48,028
   Proceeds from short-term debt                                                         56,200                       -
   Minority interest in investment in subsidiaries                                        3,733                     250
   Minority interest in dividends paid by subsidiaries                                   (1,521)                 (2,807)
   Proceeds from exercise of stock options and tax benefit
        of stock option exercises                                                         1,600                   2,557
   Payments to acquire treasury stock                                                         0                  (5,921)
                                                                                    -----------              ----------
                            Net cash provided by (used in) financing activities          54,260                 (28,456)
                                                                                    -----------              ----------
EFFECTS OF FOREIGN CURRENCY TRANSLATION                                                     654                    (305)

NET INCREASE IN CASH AND CASH EQUIVALENTS                                                 1,141                   9,793
CASH AND CASH EQUIVALENTS, as of August 31                                                8,062                   7,552
                                                                                    -----------              ----------
CASH AND CASH EQUIVALENTS, as of February 28 and as of
     February 29, respectively                                                      $     9,203              $   17,345
                                                                                    ===========              ==========
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
   Cash paid during the three months for:
         Interest paid, net of capitalized interest                                 $     1,700              $     1000
         Income taxes                                                               $       100              $      400
</TABLE>
The accompanying notes are an integral part of these statements.

<PAGE>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
          (Amounts in thousands, except percentages and share amounts)

1.  BASIS OF PRESENTATION
    ---------------------

The accompanying  unaudited consolidated financial statements have been prepared
in accordance  with the generally  accepted  accounting  principles  for interim
financial information and Article 10 of Regulation S-X. Accordingly, they do not
include all of the  information  and  footnotes  required by generally  accepted
accounting  principles  for  complete  financial  statements.  In the opinion of
management, all adjustments (consisting of normal recurring accruals) considered
necessary for the fair  presentation of the  consolidated  financial  statements
have been  included.  Due to the seasonal  nature of Delta and Pine Land Company
and subsidiaries'  (the "Company")  business,  the results of operations for the
three and six month periods ended February 28, 1999 and February 29, 2000 or for
any  quarterly  period,  are not  necessarily  indicative  of the  results to be
expected for the full year. For further information  reference should be made to
the  consolidated  financial  statements and footnotes  thereto  included in the
Company's  Annual Report to  Stockholders on Form 10-K for the fiscal year ended
August 31, 1999.

Certain  prior year balances  have been  reclassified  to conform to the current
year presentation.

2.   ABANDONMENT OF MERGER BY MONSANTO

On May 8, 1998,  the  Company  entered  into a merger  agreement  with  Monsanto
Company  ("Monsanto"),  pursuant to which the  Company  would be merged with and
into Monsanto.

On December  20,  1999,  Monsanto  withdrew its  pre-merger  notification  filed
pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act")
effectively  terminating  Monsanto's efforts to gain government  approval of the
merger. On December 30, 1999, the Company filed suit (the "December 30 suit") in
the First Judicial District of Bolivar County, Mississippi, seeking, among other
things,  the  payment of the $81  million  termination  fee due  pursuant to the
merger agreement,  compensatory damages of $1 billion and punitive damages in an
amount to be proved at trial from Monsanto's  breach of contract.  On January 2,
2000,  the Company and Monsanto  reached an agreement  whereby the Company would
withdraw  the  December 30 suit,  and  Monsanto  would  immediately  pay the $81
million.  The parties  agreed to negotiate in good faith over the  following two
weeks and Monsanto agreed to make members of its senior management  available to
conduct such negotiations.  It was also agreed that if no consensual  resolution
was reached, the lawsuit brought by the Company would be re-filed. On January 3,
2000,  Monsanto paid to the Company a termination fee of $81 million as required
by the  merger  agreement.  On January  18,  2000,  the  Company  re-filed  suit
reinstating  essentially  all of the  allegations  contained  in the December 30
suit.

The  $81  million  termination  fee,  net of  related  expenses,  is  separately
presented in the income statement.

<PAGE>

3.   RECENT ACCOUNTING PRONOUNCEMENTS
     --------------------------------

SFAS No.  130,  "Reporting  Comprehensive  Income",  establishes  standards  for
reporting  comprehensive  income and its  components  in  financial  statements.
Comprehensive income, as defined,  includes all non-shareowner changes in equity
and consists of net income, foreign currency translation adjustments, unrealized
gains and losses on available-for-sale securities, and minimum pension liability
adjustments.  Total  comprehensive  income  for the three and six  months  ended
February 28, 1999 and February 29, 2000 was (in thousands):
<TABLE>
<CAPTION>

                                                             Three Months Ended                    Six Months Ended
                                                        February 28,      February 29,      February 28,      February 29,
                                                                1999           2000                1999            2000
                                                                ----           ----                ----            ----
<S>                                                               <C>           <C>                 <C>              <C>
Net (loss) income                                            $ 2,406       $ 58,635            $ (4,032)        $ 49,119
Other comprehensive (loss) income:
     Foreign currency translation (losses) and gains            (369)           181                 654             (305)
     Income  tax  benefit  (expense)  related to other
     comprehensive income                                        139            (68)               (247)             115
                                                                 ---            ---                 ---              ---
Other comprehensive (loss) income, net of tax                   (230)           113                 407             (190)
                                                                 ---            ---                 ---              ---
Total   comprehensive   (loss)  income  applicable  to
     common stockholders                                     $ 2,176       $ 58,748            $ (3,625)        $ 48,929
                                                             =======       ========            ========         ========
</TABLE>


SFAS  No.  131,  "Disclosures  about  Segments  of  an  Enterprise  and  Related
Information," establishes standards for the way that public business enterprises
report information about operating  segments in annual financial  statements and
requires that those  enterprises  report  selected  information  about operating
segments in interim financial reports issued to shareholders.  The Company is in
a single line of business and operating in two business  segments,  domestic and
international.   The  Company's  reportable  segments  offer  similar  products;
however,  the  business  units  are  managed  separately  due to the  geographic
dispersion of their  operations.  The Company's chief  operating  decision maker
utilizes  revenue  information  in  assessing  performance  and  making  overall
operating  decisions and resource  allocations.  Profit and loss  information is
reported  by segment to the chief  operating  decision  maker and the  Company's
Board of Directors.

Information  about the  Company's  segments  for the three and six months  ended
February 28, 1999 and February 29, 2000 is as follows (in thousands):
<TABLE>
<CAPTION>

                                              Three Months Ended                        Six Months Ended
                                     February 28,             February 29,       February 28,          February 29,
                                            1999                 2000                1999                   2000
                                            ----                 ----                ----                   ----
<S>                                          <C>                  <C>                 <C>                    <C>
Net Sales
     Domestic                         $   65,164           $   89,483          $   66,251              $  89,925
     International                         7,636               14,720              13,745                 18,826
                                           -----               ------              ------                 ------
                                         $72,800             $104,203          $   79,996              $ 108,751
                                         =======             ========          ==========              =========

Operating Income/(Loss)
     Domestic                         $    5,297           $   88,650          $   (4,262)             $  78,617
     International                         (128)                5,482                (162)                 4,668
                                           ----                 -----                ----                  -----
                                      $    5,169           $   94,132          $   (4,424)             $  83,285
                                      ==========           ==========          ==========              =========
</TABLE>

Material Changes in
Assets:


     Inventories  increased  approximately 26,391 to 74,118 at February 29, 2000
     from 47,727 at August 31, 1999. This increase  reflects the seasonal nature
     of the Company's  business.  The domestic segment of the Company  purchases
     bulk seed in its first and second fiscal quarters and begins production for
     the current year's selling  season.  The increase at February 29, 2000 from
     August 31, 1999, in inventories and accounts  payable is primarily  related
     to those events and is consistent with Company's historical experience.

     Accounts receivable  decreased  approximately 20,312 to 127,614 at February
     29,  2000 from  147,926 at August 31,  1999.  This  decrease  is  primarily
     related to the  collection  of  technology  fees  sublicense  revenue  from
     Monsanto  partially offset by second quarter sales in both the domestic and
     international divisions.  Subsequent to receipt of the technology fees from
     Monsanto,  the Company  paid  Monsanto  its royalty  for the  Bollgard  and
     Roundup Ready licensing fees which is reflected in the reduction of accrued
     expenses from August 31, 1999 to February 29, 2000.

SFAS No. 133,  "Accounting for Derivative  Instruments and Hedging  Activities,"
establishes  accounting and reporting standards for the derivative  instruments,
including certain derivative  instruments  embedded in other contracts,  and for
hedging  activities.  The effective  date of this  statement was delayed via the
issuance of SFAS No. 137. The effective  date for SFAS No. 133 is now for fiscal
years beginning after June 15, 2000,  though earlier  adoption is encouraged and
retroactive  application is prohibited.  Therefore D&PL must adopt the statement
no later than September 1, 2000. Management does not expect the adoption of this
statement to have a material  impact on D&PL's results of operations,  financial
position or cash flows.

SOP 98-5,  "Reporting on the Costs of Startup  Activities,"  requires that costs
related to  start-up  activities  be expensed  as  incurred  and all  previously
capitalized  costs be written  off.  Effective  September  1, 1999,  the Company
adopted the  requirements  of SOP 98-5.  The effect of adopting  this  statement
resulted in a write-off,  net of tax, of approximately $2,965,000 ( or $0.08 per
share).  The adjustment of $2,965,000,  after income tax benefits of $1,817,000,
to retroactively apply the new method, is recorded in income of the first fiscal
quarter of 2000.

4.  INVENTORIES

Inventories consisted of the following (in thousands):
<TABLE>
<CAPTION>

                                                     February 28,       August 31,      February 29,
                                                             1999             1999              2000
                                                 ----------------  ---------------    --------------
<S>                                                           <C>              <C>                <C>
Finished goods                                     $       88,145      $    43,528    $       57,289
Raw materials                                              18,456           15,774            25,835
Growing crops                                                 396            1,564               360
Supplies and other                                            656              969               537
                                                   --------------   -------------- -----------------
                                                          107,653           61,835            84,021
Less reserves                                                (779)         (14,108)           (9,903)
                                                   ---------------  ---------------  ----------------
                                                 $        106,874     $     47,727    $       74,118
                                                 ================     ============    ==============
</TABLE>

Substantially  all finished  goods and raw  material  inventory is valued at the
lower of average cost or market. Growing crops are recorded at cost.

5.  PROPERTY, PLANT AND EQUIPMENT
    -----------------------------

Property, plant and equipment consisted of the following (in thousands):
<TABLE>
<CAPTION>

                                                   February 28,           August 31,          February 29,
                                                           1999                 1999                  2000
                                                 --------------        -------------        --------------
<S>                                                        <C>                   <C>                  <C>
Land and improvements                            $        3,995        $       4,113        $        4,119
Buildings and improvements                               35,084               35,251                37,325
Machinery and equipment                                  42,512               43,291                46,378
Germplasm                                                 7,500                7,500                 7,500
Breeder and foundation seed                               2,000                2,000                 2,000
Construction in progress                                  3,431                4,789                 2,057
                                                 --------------        -------------        --------------
                                                         94,522               96,944                99,379
Less accumulated depreciation                           (28,750)             (31,778)              (34,735)
                                                 --------------        -------------        --------------
                                                 $       65,772        $      65,166        $       64,644
                                                 ==============        =============        ==============
</TABLE>

6.  CONTINGENCIES

On October 14, 1999, the Company,  Monsanto and UAP/GA Ag. Chem. Inc. were named
as defendants in two lawsuits  filed by two cotton  farmers in the United States
District  Court for the Western  District of North  Carolina.  The suits allege,
among other things,  that certain varieties sold by the Company that contain the
Roundup Ready gene, performed poorly,  specifically  including lack of tolerance
to Roundup and poor germination.  The Company and Monsanto have investigated the
claims to determine the cause or causes of the alleged problems. Pursuant to the
terms  of the  Roundup  Ready  Agreement  between  D&PL and  Monsanto,  D&PL has
tendered  the  defense of these  claims to  Monsanto  and  requested  indemnity.
Pursuant to the Roundup Ready Agreement,  Monsanto is contractually obligated to
defend and indemnify the Company  against all claims  arising out of the failure
of the  Roundup  glyphosate  tolerance  gene.  D&PL  will  not  have a right  to
indemnification  from  Monsanto,  however,  for any  claim  involving  defective
varietal  characteristics  separate  from or in  addition  to the failure of the
herbicide  tolerance  gene,  and such claims are contained in these  complaints.
D&PL believes these claims will be resolved  without any material  impact on the
Company's consolidated financial statements.

On June 11, 1999, D&PL, Monsanto, Asgrow Seed Company, SF Services, Terral Seed,
Inc.,  Valley Farmers Co-Op, Red River Co-Op, and Central  Louisiana Grain Co-Op
were named as  defendants in a lawsuit  filed in the Fourth  Judicial  District,
Parish of  Natchitoches,  State of  Louisiana.  The suit  alleges,  among  other
things,  that certain soybean seeds which contain the Roundup  Ready(R) gene did
not perform as advertised and did not produce promised yields. The plaintiffs in
this case are  seeking  certification  of a class of all  purchasers  of Roundup
Ready  soybeans  during the years of 1997 and 1998. The Company and Monsanto are
presently  investigating the claim; however, they believe it to be without merit
and their plan is to vigorously  defend this  lawsuit.  Pursuant to the terms of
the Roundup Ready Soybean Agreement between D&PL and Monsanto, D&PL has tendered
the defense of this claim to  Monsanto.  Pursuant to the Roundup  Ready  Soybean
Agreement,  Monsanto is contractually  obligated to defend and indemnify any and
all claims arising out of the failure of glyphosate gene tolerance,  and certain
other types of claims. D&PL will have no right to indemnification from Monsanto,
however,   for  any  claim   involving   defects  in  seed  and/or   promotional
representations  made solely by D&PL without  Monsanto's  approval.  Such claims
appear to be contained  within this complaint.  D&PL believes this claim will be
resolved  without any material  impact on the Company's  consolidated  financial
statements.

The Company and Monsanto are named as defendants in four pending  lawsuits filed
in the State of Texas. Two lawsuits were filed in Lamb County, Texas on April 5,
1999;  one lawsuit was filed in Lamb County,  Texas on April 14,  1999;  and one
lawsuit was filed in Hockley County,  Texas,  on April 21, 1999.  These lawsuits
were  removed  to the  United  States  District  Court,  Lubbock  Division,  but
subsequently  were  remanded  back to the state court where they were filed.  In
each case the plaintiff  alleges,  among other things,  that certain  cottonseed
acquired from Paymaster  which  contained the Roundup Ready gene did not perform
as the farmers had  anticipated.  These  lawsuits also include  varietal  claims
aimed solely at the Company.  This  litigation is identical to seed  arbitration
claims  previously  filed in the  State of Texas  which  were  concluded  in the
Company's  favor.  The  Company and  Monsanto  have  investigated  the claims to
determine the cause or causes of the alleged problems.  Pursuant to the terms of
the Roundup Ready  Agreement  between D&PL and  Monsanto,  D&PL has tendered the
defense of these claims to Monsanto  and  requested  indemnity.  Pursuant to the
Roundup  Ready  Agreement,  Monsanto is  contractually  obligated  to defend and
indemnify  the  Company  against  all claims  arising  out of the failure of the
Roundup glyphosate tolerance gene. D&PL will not have a right to indemnification
from   Monsanto,   however,   for  any  claim   involving   defective   varietal
characteristics  separate  from or in addition  to the failure of the  herbicide
tolerance gene, and such claims are contained in these complaints. D&PL believes
these  claims will be  resolved  without any  material  impact on the  Company's
consolidated financial statements.

The Company,  Monsanto and other  parties were named as  defendants in a lawsuit
filed in the Superior Court of Calhoun County,  Georgia on April 19, 1999, which
has been removed to the United States  District Court of the Middle  District of
Georgia,  Albany Division. The Company and Monsanto are presently  investigating
the claim to  determine  the cause or causes,  if any, of the alleged  problems.
Pursuant to the terms of the Roundup Ready Agreement  between D&PL and Monsanto,
D&PL has tendered the defense of this claim to Monsanto and requested indemnity,
as Monsanto  is  contractually  obligated  to defend and  indemnify  the Company
against  all  claims  arising  out of the  failure  of  the  Roundup  glyphosate
tolerance  gene.  D&PL will not have a right to  indemnification  from Monsanto,
however, for any claim involving defects in seed separate from or in addition to
the failure of the herbicide  tolerance  gene,  and such claims are contained in
these complaints.  This case was the subject of a seed arbitration case filed in
Georgia  during 1997 which was concluded in the Company's  favor.  D&PL believes
this  lawsuit  will be resolved  without any  material  impact on the  Company's
consolidated financial statements.

On November 15, 1999,  Monsanto and local cotton seed distributors were named in
a lawsuit filed in the Court of Common Pleas, County of Hampton,  State of South
Carolina.  This case was  subsequently  removed  to the United  States  District
Court, District of South Carolina,  Beaufort Division.  This case requests class
action  treatment  and alleges that a wide variety of the  Company's  transgenic
cotton  products were defective  because they grew plants which produced  cotton
bolls that  contained  immature,  defective  and rotten  seed in the bolls.  The
plaintiff in this case seeks class  certification of purchases of a wide variety
of seed  purchased  during the 1999 crop year.  The  Company  and  Monsanto  are
presently  investigating the claim; however, they believe it to be without merit
and their plan is to vigorously defend this lawsuit, with particular emphasis on
defending the class action allegations.  The Company has tendered the defense of
this claim to Monsanto and requested indemnity. Pursuant to the Roundup Ready(R)
Agreement,  Monsanto is  contractually  obligated  to  indemnify  and defend the
Company  against all claims arising out the failure of the glyphosate  tolerance
gene.  The  Company  will  not have a right to  indemnification  from  Monsanto,
however,  for any claim involving  defective varietal  characteristics  separate
from or in addition to the failure of the  herbicide  tolerance  gene,  and such
claims are contained in these complaints. The Company believes this claim is not
one that is likely to receive class treatment.  Accordingly,  D&PL believes that
this  claim  will be  resolved  without  any  material  impact on the  Company's
consolidated financial statements.

On November  15,  1999,  the  Company,  Monsanto  and certain  local  cottonseed
distributors  were  named in an  additional  case  filed in the  Court of Common
Pleas, County of Hampton State of South Carolina.  This case has been removed to
the United States District Court, District of South Carolina, Beaufort Division.
This  case  alleges  that a wide  variety  of the  Company's  transgenic  cotton
products were defective because they grew plants that produced cotton bolls that
contained immature,  defective and rotten seed in the bolls during the 1999 crop
year. The Company and Monsanto are presently  investigating the claim;  however,
they believe it to be without merit and their plan is to vigorously  defend this
lawsuit.  The Company  has  tendered  the defense of this claim to Monsanto  and
requested  indemnity.  Pursuant to the Roundup Ready(R)  Agreement,  Monsanto is
contractually  obligated to indemnify and defend the Company  against all claims
arising out the failure of the glyphosate  tolerance  gene. The Company will not
have a right to indemnification from Monsanto,  however, for any claim involving
defective varietal  characteristics  separate from or in addition to the failure
of the  herbicide  tolerance  gene,  and  such  claims  are  contained  in  this
complaint.  The Company  believes  that this claim will be resolved  without any
material impact on the Company's consolidated financial statements.

On November  15,  1999,  the  Company,  Monsanto  and certain  local  cottonseed
distributors  were name in a  lawsuit  filed in United  States  District  Court,
District of South Carolina,  Beaufort Division.  This case requests class action
treatment  and alleges that a wide variety of the  Company's  transgenic  cotton
products  were  defective  because they grew plants that  produced  cotton bolls
containing  immature,  defective and rotten seed in the bolls.  The plaintiff in
this case seeks  class  certification  of  purchases  of a wide  variety of seed
purchased  during the 1999 crop year.  The Company and  Monsanto  are  presently
investigating the claim;  however, they believe it to be without merit and their
plan is to vigorously defend this lawsuit, with particular emphasis on defending
the class action allegations. The Company has tendered the defense of this claim
to Monsanto and requested indemnity. Pursuant to the Roundup Ready(R) Agreement,
Monsanto is contractually  obligated to indemnify and defend the Company against
all claims arising out the failure of the glyphosate tolerance gene. The Company
will not have a right to indemnification  from Monsanto,  however, for any claim
involving defective varietal characteristics separate from or in addition to the
failure of the herbicide  tolerance gene, and such claims are contained in these
complaints. The Company believes this claim is not one that is likely to receive
class  treatment.  Accordingly,  D&PL  believes that this claim will be resolved
without any material impact on the Company's consolidated financial statements.

On March  30,  1999,  the  Company,  Asgrow  Seed  Company,  L.L.C.,  and  Terra
International were named as defendants in a lawsuit filed in the Fourth Judicial
District  Court,  Parish of Morehouse,  State of  Louisiana,  which has now been
removed  to the  United  States  District  Court  for the  Western  District  of
Louisiana. The suit alleges, among other things, that certain soybean seed which
contained the Roundup Ready gene did not properly  germinate and did not perform
as the farmer had  anticipated  and, in particular,  did not fully protect their
crops from damage following the application of Roundup. The Company and Monsanto
are presently  investigating the claim to determine the cause or causes, if any,
of the alleged  problem.  Pursuant to the terms of the Roundup  Ready  Agreement
between  D&PL and  Monsanto,  D&PL has  tendered  the  defense  of this claim to
Monsanto.  Pursuant to the Roundup Ready  Agreement,  Monsanto is  contractually
obligated to defend and indemnify any and all claims  arising out of the failure
of the  glyphosate  tolerance  gene.  D&PL  believes  this case can be  resolved
without any material impact on the Company's consolidated financial statements.

Sixteen farmers in Mississippi  have filed seed  arbitration  claims against the
Company with the Mississippi  Department of Agriculture  arising from their 1999
crop. Pursuant to the terms of the Bollgard Gene Licensing Agreement,  Delta and
Pine Land Company has tendered the defense of these claims to Monsanto, Monsanto
is  contractually  obligated to defend and indemnify the Company  against claims
arising  from  a  failure  of the  Bollgard  gene.  Monsanto  has  declined  the
assumption of defense and indemnity of these cases and, indeed,  it appears that
the cases do not involve a complaint of the failure of the gene technology.  The
Mississippi  Department of Agriculture has not yet scheduled a hearing on any of
these claims. The Company has moved to dismiss many of the claims as having been
untimely filed.  The Company  believes these claims can be resolved  without any
material impact on the Company's consolidated financial statement.

In 1999,  approximately  189 cotton  farmers in Georgia  filed seed  arbitration
cases against the Company and, in some cases, against Monsanto, alleging damages
for their 1999 crops. Although hearings were originally scheduled for 6 of these
claims in January of 2000, the Georgia Seed Arbitration  Council dismissed those
cases without hearing  determining that the claims fell outside the jurisdiction
of that body.  Similar orders of dismissal have been entered for 145 other cases
pending before the Georgia Seed Arbitration Council and it is anticipated that a
significant  number of the remaining  cases will  likewise be dismissed  without
hearing.  The Company and  Monsanto  are in the process of  investigating  these
claims to  determine  the cause or  causes,  if any,  of the  alleged  problems.
Pursuant to the terms of the Roundup Ready Agreement  between D&PL and Monsanto,
D&PL has tendered the defense of these seed  arbitration  claims to Monsanto and
has requested  indemnity.  Pursuant to the Roundup Ready Agreement,  Monsanto is
contractually  obligated to defend and indemnify the Company  against all claims
arising out of the failure of the Roundup glyphosate tolerance gene. The Company
will not have a right  to  indemnification,  however,  for any  claim  involving
defects  in the  seed,  separate  from  or in  addition  to the  failure  of the
herbicide  tolerance  gene,  and such claims are  contained  in some of the seed
arbitration claims filed.  Based upon information  received to date, the Company
believes  these  claims  can be  resolved  without  any  material  impact on the
Company's consolidated financial statements.

In 1998,  one claim was filed with the  Arkansas  Seed  Arbitration  Council.  A
Motion to Dismiss has been filed.  This case alleges that certain  Roundup Ready
cottonseed  marketed  by the  Company in 1997  failed to perform as farmers  had
anticipated and caused the farmers to suffer crop loss.  Pursuant to the Roundup
Ready Agreement between D&PL and Monsanto, D&PL has tendered the defense of this
claim  to  Monsanto.  Pursuant  to the  Roundup  Ready  Agreement,  Monsanto  is
contractually  obligated to defend and indemnify any and all claims  arising out
of the failure of the glyphosate gene tolerance. D&PL has requested dismissal of
this claim  alleging  that it was untimely  filed.  The Arkansas  Department  of
Agriculture  has not yet  scheduled a hearing on this claim.  D&PL believes this
case can be resolved  without any material impact on the Company's  consolidated
financial statements.

During 1999, five farmers in the State of Alabama filed seed arbitration  claims
against the  Company for their 1999 crop year.  The Company is in the process of
investigating  these  claims to  determine  the cause or causes,  if any, of the
alleged  problems.  Pursuant to the terms of the Roundup Ready Agreement between
D&PL and  Monsanto,  D&PL has  tendered  the  defense of these seed  arbitration
claims to Monsanto and has  requested  indemnity.  Pursuant to the Roundup Ready
Agreement,  Monsanto is  contractually  obligated  to defend and  indemnify  the
Company against all claims arising out of the failure of the Roundup  glyphosate
tolerance gene. The Company will not have a right to  indemnification,  however,
for any claim involving defects in the seed, separate from or in addition to the
failure of the herbicide  tolerance  gene, and such claims are contained in some
of the seed arbitration  claims filed. The Alabama Department of Agriculture has
not yet scheduled  hearing dates on any of these claims.  Based upon information
received to date, the Company  believes these claims can be resolved without any
material impact on the Company's consolidated financial statements.

Six farmers in the State of Florida have filed  arbitration  claims  against the
Company for the 1999 crop year,  however,  one was withdrawn due to high yields.
The Florida  Department of Agriculture has not yet scheduled  hearings on any of
these  claims.  The Company  believes  these claims can be resolved  without any
material impact on the Company's consolidated financial statements.

In 1999, 112 farmers in the State of South Carolina have filed seed  arbitration
claims  against the  Company.  The Company  and  Monsanto  are in the process of
investigating  these  claims to  determine  the cause or causes,  if any, of the
alleged problem. Pursuant to the terms of the Roundup Ready(R) Agreement between
the Company and  Monsanto,  the Company has  tendered  the defense of these seed
arbitration claims to Monsanto and requested indemnity.  Pursuant to the Roundup
Ready(R) Agreement,  Monsanto is contractually obligated to defend and indemnify
the  Company  against  all claims  arising  out of the  failure  of the  Roundup
glyphosate tolerance gene. D&PL will have no right to indemnification,  however,
from any claims involving  defective seed, separate from or in additional to the
failure of the herbicide  tolerance  gene, such claims are contained in the seed
arbitration  claims filed in South  Carolina.  The South Carolina  Department of
Agriculture has not yet scheduled a hearing on any of these claims.  The Company
believes  the claims to be without  merit and that the  farmers  complaints  are
environmentally  induced and not related to seed performance;  accordingly,  the
Company believes these claims can be resolved without any material impact on the
Company's consolidated financial statements.

On January 31, 2000,  the Company was named as a defendant in a lawsuit filed in
the Circuit  Court of Bolivar  County,  Mississippi.  The  Company is  presently
investigating  the claim to determine  the cause or causes of any of the alleged
problems.  This  claim  arises  from  a  seed  arbitration  case  heard  by  the
Mississippi Seed Arbitration  Council during 1999.  Pursuant to the terms of the
Roundup  Ready(R)  Agreement  between D&PL and  Monsanto,  D&PL has tendered the
defense of this claim to  Monsanto  and  requested  indemnity,  as  Monsanto  is
contractually  obligated to defend and indemnify the Company  against all claims
arising out the failure of the Roundup(R) glyphosate gene tolerance. Such claims
are made in this lawsuit and it is  anticipated  that  Monsanto  will assume the
defense of and/or  indemnify  the  Company in full for this  claim.  The Company
believes  this  lawsuit  will be  resolved  without any  material  impact on the
Company's consolidated financial statements.

In May  1998,  five  individual,  alleged  shareholders  brought  suits  against
Monsanto,  the Company and its Board of Directors  ("Directors") in the Court of
Chancery in New Castle County,  Delaware (the "Delaware  Chancery  Court").  The
complaints  alleged that the  consideration to be paid in the proposed merger of
the Company  with  Monsanto  was  inadequate  and that the  Company's  Directors
breached  their  fiduciary  duties to the  Company's  stockholders  by voting to
approve the  Agreement and Plan of Merger,  and that Monsanto  aided and abetted
the alleged breach of fiduciary duty. The complaints were  consolidated into one
action,  which sought a declaration  that the action was maintainable as a class
action,  that the merger be enjoined,  or  alternatively,  rescinded,  and/or an
award of  unspecified  compensatory  damages if the merger  was  consummated.  A
settlement  agreement was reached with the named  plaintiffs  in November  1998.
This  settlement  was  contingent  on  consummation  of the merger.  In light of
Monsanto's  termination  of the merger,  the Company  believes that this lawsuit
will be  resolved  without any  material  effect on the  Company's  consolidated
financial statements.

In  December  1999 and  January  2000,  five  individual,  alleged  shareholders
(including  some of the  plaintiffs  in the suits filed in May 1998) brought two
new suits (now consolidated) against the Directors, the Company, and Monsanto in
the  Delaware  Chancery  Court.  These  complaints  allege  that  the  Company's
Directors  breached  fiduciary  duties  by  failing  to seek  compensation  from
Monsanto  for  breach of the  Agreement  and Plan of Merger  and by  failing  to
explore strategic  alternatives  after the termination of the merger transaction
by Monsanto and that  Monsanto  aided,  abetted,  and  assisted  the  Directors'
alleged  breaches of  fiduciary  duty.  The  plaintiffs  seek to maintain  these
actions as class actions and demand injunctive relief requiring the Directors to
maximize shareholder value and, alternatively, unspecified compensatory damages,
attorneys'  fees,  and costs (See Note 2).  Monsanto has filed a cross-claim  in
those consolidated cases seeking a declaratory judgment that it is not liable to
the  Company  for breach of  contract  for  failure to  consummate  the  merger.
Monsanto seeks no monetary  recovery  against the Company.  The Company believes
that plaintiffs'  complaints,  which were filed before  plaintiffs were aware of
the actions  undertaken  by the Company and its  Directors to seek  compensation
from Monsanto and to maximize  shareholder  value in the aftermath of Monsanto's
termination of the merger transaction, are without merit and should be dismissed
without material effect on the Company's consolidated financial statements.  The
Company has moved to dismiss Monsanto's  cross-claim or, alternatively,  to stay
the  cross-claim in favor of the Company's suit against  Monsanto filed in state
court in Mississippi.

In  October  1996,   Mycogen  Plant  Science,   Inc.  and   Agrigenetics,   Inc.
(collectively  "Mycogen")  filed a lawsuit in U.S.  District  Court in  Delaware
naming D&PL,  Monsanto and DeKalb  Genetics as  defendants  alleging that two of
Mycogen's  recently  issued  patents had been  infringed  by the  defendants  by
making,  selling,  and licensing seed that contains the Bollgard gene. The suit,
which  went to  trial  in  January  1998,  sought  injunctions  against  alleged
infringement, compensatory damages, treble damages and attorney's fees and court
costs.  A jury found in favor of D&PL and  Monsanto  on issues of  infringement.
Mycogen  subsequently  re-filed a motion  for a new trial and for a judgment  in
favor of Mycogen as a matter of law. The trial court has ruled in these  motions
holding for Mycogen on certain  issues but  sustaining the jury verdict in favor
of D&PL and Monsanto.  Mycogen has appealed to the U.S. Court of Appeals for the
Federal Circuit.  Pursuant to the terms of the Bollgard  Agreement,  Monsanto is
required to defend D&PL against  patent  infringement  claims and indemnify D&PL
against damages from any patent infringement claims and certain other losses and
costs. Due to Monsanto's obligation to indemnify D&PL, the Company believes that
the  resolution of this matter will not have a material  impact on the Company's
consolidated financial statements.

In December 1999,  Mycogen Plant Science,  Inc., an Australian  affiliate of Dow
Chemical Co.  ("Mycogen-Australia") filed suit in the Federal Court of Australia
against Monsanto  Australia,  Limited and Deltapine  Australia Pty, Limited (the
Australian affiliates of Monsanto and D&PL, respectively) alleging that sales in
Australia of  genetically-modified  cotton seed  containing  Monsanto's  Bt gene
infringe two  Australian  patents held by  Mycogen-Australia.  The suit seeks to
enjoin  sales  of such  allegedly  infringing  seed in  Australia  and  monetary
damages.  This suit  involves  issues  similar  to those in the above  described
Delaware  litigation  but will be  decided  under  Australian  patent law which,
unlike the United States,  applies a "first to file" priority rule. Monsanto and
D&PL,  which are  cooperating  in  defense of this  suit,  are  relying on other
defenses  to  infringement  claims.  At the  present  time,  the outcome of this
litigation cannot be predicted.

A corporation  owned by the son of the Company's former  Guatemalan  distributor
sued in 1989  asserting  that  the  Company  violated  an  agreement  with it by
granting  to another  entity an  exclusive  license in certain  areas of Central
America and southern  Mexico.  The suit seeks  damages of  5,300,000  Guatemalan
quetzales  (approximately  $700,000 at current exchange rates) and an injunction
preventing the Company from distributing seed through any other licensee in that
region.  The  Guatemalan  court,  where  this  action is  proceeding,  has twice
declined  to  approve  the  injunction  sought.  Management  believes  that  the
resolution  of the  matter  will not have a  material  impact  on the  Company's
consolidated financial statements.  The Company continues to offer seed for sale
in Guatemala.

In November 1999, a distributor of Sure-Grow brand cotton seed in Greece brought
suit in U. S. District  Court in Delaware  seeking to enjoin the  termination of
its distributorship (which become effective on November 30, 1999), a declaratory
judgment  that  the  Company's   termination  of  its  distributorship  was  not
effective,  compensatory  damages  of not less than $6 million  and  unspecified
punitive damages.  The distributor has also filed a request for arbitration with
the American  Arbitration  Association and a suit seeking injunctive relief in a
court in  Thessaloniki,  Greece.  In January 2000,  the U. S. District  Court in
Delaware  denied the request for  injunctive  relief.  The Company has sought an
injunction  against the  distributor's  proceeding with litigation in the Greece
Court.  The Company  believes that the former  distributor's  claims are without
merit and that these claims will be resolved  without any material impact on the
Company's  consolidated  financial  statements.  The Company  continues to offer
cotton seed (including  seed of the Sure-Grow  brand) for sale in Greece through
another distributor.

On July 18, 1996, the United States  Department of Justice,  Antitrust  Division
("USDOJ"),  served a Civil Investigative Demand (the "1996 CID") on D&PL seeking
information  and  documents  in  connection  with  its   investigation   of  the
acquisition  by D&PL of the stock of Arizona  Processing,  Inc.,  Ellis Brothers
Seed, Inc. and Mississippi Seed, Inc. (which own the outstanding common stock of
Sure Grow  Seed,  Inc).  The 1996 CID  stated  that the USDOJ was  investigating
whether these  transactions may have violated the provisions of Section 7 of the
Clayton Act, 15 USC 18. D&PL responded to the 1996 CID,  employees were examined
in 1997 by the USDOJ,  and D&PL is committed to full cooperation with the USDOJ.
At the  present  time,  the  ultimate  outcome  of the  investigation  cannot be
predicted.

On August 9, 1999, D&PL and Monsanto received Civil  Investigative  Demands from
the USDOJ (the "1999 CID's"),  seeking to determine  whether there have been any
inappropriate exchanges of information between Monsanto and D&PL or if any prior
acquisitions are likely to have substantially  lessened  competition in the sale
or development  of cottonseed or cottonseed  genetic  traits.  D&PL has complied
with the USDOJ's request for  information and documents.  The USDOJ has taken no
further action on the 1999 CID's since D&PL and Monsanto's responses were filed.

7.       EARNINGS PER SHARE

The table below  reconciles  basic and diluted  earnings per share for the three
and six months ended February 28 and February 29, respectively:
<TABLE>
<CAPTION>

                                                                         Three Months                    Six Months
Basic:                                                              1999            2000           1999              2000
- ------                                                              ----            ----           ----              ----
<S>                                                                  <C>             <C>            <C>               <C>
Income/(Loss) before cumulative effect of accounting
  change                                                          $2,406        $ 58,635       $ (4,032)          $52,084
Preferred stock dividends
                                                                     (24)            (40)           (48)              (64)
                                                                     ---             ---            ---               ---
Net income/(loss) before cumulative effect of accounting
  change applicable to common  stockholders
                                                                  $2,382        $ 58,595       $ (4,080)          $52,020
                                                                  ======        ========       ========           =======
Weighted average shares outstanding
                                                                  38,422          38,644         38,397            38,653
                                                                  ======          ======         ======            ======
Basic earnings per share before cumulative effect of
  accounting change                                               $ 0.06        $   1.52       $  (0.11)          $  1.35
                                                                  ======        ========       ========           =======

Diluted:
Net income/(loss) before cumulative effect of accounting
  change applicable to common stockholders                        2,382           58,595       $ (4,080)          $52,020
Add Back:

Preferred stock dividends                                            24               40             48                64
                                                                     --               --             --                --
Net Income/(loss) before cumulative effect of accounting
  change                                                         $2,406          $58,635       $ (4,032)          $52,084
                                                                 ======          =======       ========           =======
Diluted shares outstanding                                       40,819           40,110         38,397            40,186
                                                                 ======           ======         ======            ======
Diluted earnings per share before cumulative effect of
  accounting change                                                0.06             1.46       $  (0.11)          $  1.29
                                                                 ======           ======       ========           =======
</TABLE>


PART I.

Item 2. Management's  Discussion and Analysis of Financial Condition and Results
     of Operations

Overview

On May 8,  1998,  Delta and Pine  Land  Company  and  subsidiaries,  a  Delaware
Corporation  ("D&PL" or the  "Company")  entered  into a merger  agreement  with
Monsanto  Company  ("Monsanto"),  pursuant to which Delta and Pine Land  Company
would be merged with and into Monsanto.

On December  20,  1999,  Monsanto  withdrew its filing under the HSR Act thereby
effectively  abandoning  plans to  consummate  the  merger.  On January 3, 2000,
Monsanto paid Delta and Pine Land Company an $81 million termination fee, which,
net of related  expenses,  is separately  presented in the  accompanying  income
statement.  The diluted per share effect of this  non-recurring  payment (net of
related  expenses)  was $1.16 and  $1.15  for the  three  and six  months  ended
February 29, 2000, respectively.

RESULTS OF OPERATIONS

The following sets forth selected operating data of the Company (in thousands):
<TABLE>
<CAPTION>

                                              For the Three Months Ended         For the Six Months Ended
                                              --------------------------         ------------------------
                                              February 28,   February 29,    February 28,       February 29,
                                                      1999           2000            1999              2000
                                                    ------        -------          ------             -----
<S>                                                    <C>            <C>             <C>               <C>
Operating results -
Net sales and licensing fees                      $ 72,800      $ 104,203        $ 79,996         $ 108,751
Gross profit                                        49,684         73,162          25,444            31,341
Operating expenses:
     Research and development                        4,880          5,022           9,115             9,381
     Selling                                         3,848          3,596           7,678             6,833
     General and administrative                      3,094          2,985           6,053             6,069
     Special charges and unusual item                6,125        (74,694)          7,022           (74,227)
Operating income/(loss)                              5,169         94,132          (4,424)           83,285
Income/(loss) before income taxes and
     cummulative effect of accounting change         4,278         93,900          (6,083)           83,334
Net income/(loss) applicable to common shares
      before accounting change                       2,406         58,635         (4,080)            49,055
</TABLE>


The following  sets forth  selected  balance sheet data of the Company as of the
following periods (in thousands):
<TABLE>
<CAPTION>

                                                  February 28,           August 31,           February 29,
                                                      1999                  1999                  2000
                                               -----------------     -----------------     ------------------
<S>                                                         <C>                   <C>                     <C>
Balance sheet summary-
Current assets                                     $    218,406           $   217,543           $    233,615
Current liabilities                                     151,706               175,243                163,329
Working capital                                          66,700                42,300                 70,286
Property, plant and equipment, net                       65,772                65,166                 64,644
Total assets                                            294,324               295,758                310,402
Outstanding borrowings                                  101,106                20,819                    663
Stockholders' equity                                     76,548                89,404                132,475
</TABLE>

Three months ended  February 29, 2000,  compared to three months ended  February
28, 1999:

Net sales and licensing  fees  increased  approximately  $31.4 million to $104.2
million  from $72.8  million.  The increase in net sales and  licensing  fees is
primarily the result of an approximate 5% increase in anticipated planted cotton
acreage in the United States. In addition,  the company is experiencing stronger
demand for its  varieties  which  contain the  Bollgard  and Roundup  Ready gene
technologies   resulting  in  higher  revenue  from  its  technology   licensing
agreements.  The International  division  experienced  increased export sales to
Greece. In addition, sales by the previously formed Brazilian joint venture were
successful during its first full selling season.

Operating  expenses decreased from $11.8 million in the second fiscal quarter of
1999 to $11.6 million in fiscal 2000. This decrease is primarily attributable to
cost savings as which are the result of the  Company's  July 1999  restructuring
program.

The Company  reported net interest expense of $0.27 million in the second fiscal
quarter of 2000 compared to net interest  expense of $1.10 million in the second
fiscal  1999.  This  change  is  primarily  due  to  lower  average  outstanding
borrowings and higher  interest rates earned on cash  equivalents as a result of
the receipt of the $81.0 million merger break-up fee received from Monsanto.

Six months ended February 2000, compared to three months ended February 1999:

Net sales and licensing  fees  increased  approximately  $28.7 million to $108.7
million  from $80  million.  The  increase  in net sales and  licensing  fees is
primarily the result of an approximate 5% increase in anticipated planted cotton
acreage in the United States. In addition,  the Company is experiencing stronger
demand for its  varieties  which  contain the  Bollgard  and Roundup  Ready gene
technologies   resulting  in  higher  revenue  from  its  technology   licensing
agreements.

Operating  expenses  decreased  from  $22.8  million  in the first six months of
fiscal  1999 to $22.3  million  in  fiscal  2000.  This  decrease  is  primarily
attributable  to cost savings as which are the result of the Company's July 1999
restructuring program.

The Company  reported net interest  income of $0.19  million in the first fiscal
quarter of 2000  compared to net interest  expense of $1.62 million in the first
six months of fiscal  quarter of 1999.  This  change is  primarily  due to lower
average  outstanding  borrowings  and  higher  interest  rates  earned  on  cash
equivalents as a result of the receipt of the $81.0 million merger  break-up fee
received from Monsanto.

LIQUIDITY AND CAPITAL RESOURCES

The seasonal nature of the Company's  business  significantly  impacts cash flow
and working capital requirements.  The Company maintains credit facilities, uses
early  payments  by  customers  and uses cash from  operations  to fund  working
capital needs. For more than 18 years D&PL has borrowed on a short-term basis to
meet seasonal working capital needs.

In the United States, D&PL purchases seed from contract growers in its first and
second fiscal quarters. Seed conditioning,  treating and packaging commence late
in the first  fiscal  quarter and  continue  through the third  fiscal  quarter.
Seasonal  borrowings  normally  commence in the first fiscal quarter and peak in
the third fiscal quarter.  Loan  repayments  normally begin in the middle of the
third fiscal quarter and are typically  completed by the first fiscal quarter of
the following  year.  D&PL also offers  customers  financial  incentives to make
early payments. To the extent D&PL attracts early payments from customers,  bank
borrowings under the credit facility are reduced.

The Company records receivables for licensing fees on Bollgard and Roundup Ready
seed sales as the seed is  shipped,  usually in the  Company's  second and third
quarters.  The Company has contracted the billing and collection  activities for
Bollgard  and Roundup  Ready  licensing  fees to  Monsanto.  In  September,  the
technology fees are due at which time D&PL receives payment from Monsanto.  D&PL
then pays  Monsanto  its royalty for the Bollgard  and Roundup  Ready  licensing
fees.

In April 1998, the Company  entered into a syndicated  credit  facility with its
existing  lender  and  two  other  financial  institutions  which  provides  for
aggregate borrowings of $110 million.  This agreement provides a base commitment
of $55 million and a seasonal commitment of $55 million.  The base commitment is
a long-term loan that may be borrowed upon at any time and is due April 1, 2001.
The seasonal  commitment  is a working  capital loan that may be drawn upon from
September 1 through June 30 of each fiscal year and expires April 1, 2001.  Each
commitment  offers  variable  and fixed  interest  rate options and requires the
Company to pay facility or commitment fees and to comply with certain  financial
covenants.  At February 29, 2000,  the Company had $55.0  million  available for
borrowing  under the base  commitment  and  $54.3  million  available  under its
seasonal  commitment.  In addition the lead lender has approved a $25.0  million
credit line that can be  activated  by the Company as needed.  Such  facility is
generally available for up to 180 days and bears interest at rates comparable to
the existing facility.

The financial  covenants under the loan  agreements  require the Company to: (a)
maintain a ratio of total  liabilities  to  tangible  net worth at August 31, of
less than or equal to 2.25 to 1 (4.0 to 1.0 at the Company's other quarter ends)
(b) maintain a fixed  charge  ratio at the end of each  quarter  greater than or
equal to 2.0 to 1.0 and (c) maintain at all times tangible net worth of not less
than the sum of (i) $40  million  plus (ii) 50% of net income  (but not  losses)
determined on the last day of each fiscal year, commencing with August 31, 1998.
At February 29, 2000, the Company was in compliance with these covenants.

Capital  expenditures  for the first six months of 2000 were $3.0 million  which
was a decrease  from $5.0  million in the first six months of 1999.  The Company
anticipates that domestic capital  expenditures will approximate $8.0 million in
2000,  excluding expected capital  expenditures for foreign joint ventures which
will be funded by cash from  operations,  borrowings or  investments  from joint
venture partners,  as necessary.  Capital expenditures in 2000 for international
ventures are  expected to range from $1.0  million to $2.0 million  depending on
the timing and outcome of such projects.

Cash provided from  operations,  early  payments from  customers and  borrowings
under the loan agreement should be sufficient to meet the Company's 2000 working
capital needs.

In the second  quarter  of fiscal  2000,  the Board of  Directors  authorized  a
quarterly  dividend of $0.03 per share,  paid March 13, 2000 to the stockholders
of record on February 29, 2000. It is anticipated  that  quarterly  dividends of
$0.03 per share will continue to be paid although the Board of Directors reviews
this policy quarterly.

In  January  2000,  the Board of  Directors  approved  a stock  repurchase  plan
pursuant to which the  Company  expects to  purchase  up to  $50,000,000  of its
outstanding  common  stock.  The  shares  repurchased  will  be used  for  stock
issuances  pursuant to the Company's  stock option plans and for other corporate
purposes.


<PAGE>


PART II.   OTHER INFORMATION

Item 1.  Legal Proceedings

See Part I, Item 1, Footnote 6

Item 4.  Submission of Matters to a Vote of Security Holders

Not applicable

Item 5.  Business

Domestic

On May 8,  1998,  Delta and Pine Land  Company  ("DPLC")  entered  into a Merger
Agreement with Monsanto Company ("Monsanto"),  pursuant to which DPLC would have
been merged with and into Monsanto.  On December 20, 1999, Monsanto withdrew its
pre-merger  notification  filed  pursuant  to the  HSR Act  thereby  terminating
Monsanto's  efforts to obtain  government  approval of the merger. On January 3,
2000  Monsanto  paid  DPLC  the $81  million  termination  fee  pursuant  to the
agreement.

Delta and Pine Land Company, a Delaware corporation, and subsidiaries ("D&PL" or
the "Company") is primarily  engaged in the breeding,  production,  conditioning
and  marketing of  proprietary  varieties of cotton  planting seed in the United
States  and  other  cotton  producing  nations.  D&PL  also  breeds,   produces,
conditions and distributes soybean planting seed in the United States.

Since 1915, D&PL has bred,  produced and/or marketed upland picker  varieties of
cotton planting seed for cotton varieties that are grown primarily east of Texas
and in Arizona.  The Company has used its  extensive  classical  plant  breeding
programs to develop a gene pool  necessary for producing  cotton  varieties with
improved  agronomic  traits  important  to farmers,  such as crop yield,  and to
textile manufacturers, such as enhanced fiber characteristics.

In 1980,  D&PL added soybean seed to its product line. In 1996,  D&PL  commenced
commercial  sales in the  United  States  of  cotton  planting  seed  containing
Bollgard(R)  gene  technology  licensed from Monsanto which  expresses a protein
toxic to certain lepidopteran cotton pests. Since 1997, D&PL has marketed in the
U.S.  cotton  planting  seed that  contains a gene that  provides  tolerance  to
glyphosate-based herbicides ("Roundup Ready(R) Cotton"). In 1997, D&PL commenced
commercial  sales in the U.S. of soybean planting seed that contains a gene that
provides tolerance to glyphosate-based herbicides ("Roundup Ready Soybeans").

International

During the 1980's, as a component of its long-term growth strategy,  the Company
began to market its  products,  primarily  cottonseed,  internationally.  Over a
period of years,  the Company has  strengthened  and expanded its  international
staff  in order to  support  its  expanding  international  business,  primarily
through joint ventures.  In foreign  countries,  cotton acreage is often planted
with  farmer-saved  seed which has not been  delinted  or treated  and is of low
overall quality.  Management believes that D&PL has an attractive opportunity to
penetrate  foreign  markets  because of its widely  adaptable,  superior  cotton
varieties,  technological  know-how in producing and  conditioning  high-quality
seed and brand name  recognition.  Furthermore,  in many  countries the Bollgard
gene  technology  and Roundup  Ready gene  technology  licensed from Monsanto is
effective and could bring value to farmers.

D&PL sells its products in foreign  countries  through (i) export sales from the
U.S.,  (ii)  direct   in-country   operations  and  to  a  lesser  degree  (iii)
distributors  or licensees.  The method varies and evolves,  depending  upon the
Company's  assessment of the  potential  size and  profitability  of the market,
governmental policies,  currency and credit risks,  sophistication of the target
country's  agricultural  economy, and costs (as compared to risks) of commencing
physical  operations in a particular  country.  Prior to 1999, a majority of the
Company's  international  sales  resulted  from  exports  from the  U.S.  of the
Company's  products rather than direct  in-country  operations.  In 1999, direct
in-country  operations  through  joint  ventures  or  subsidiaries   (primarily,
Australia,   China  and  South   Africa)   comprised   over  one-half  of  total
international sales which represent approximately 15% of consolidated sales.

Joint Ventures

D&M  International,  LLC, is a venture  formed in 1995  through  which D&PL (the
managing member) and Monsanto plan to introduce, in combination, cotton planting
seed in international  markets  combining  D&PL's acid delinting  technology and
elite germplasm and Monsanto's Bollgard and Roundup Ready gene technologies.  In
November 1995, D&M International,  LLC formed a subsidiary,  D&PL China Pte Ltd.
("D&PL  China").  In November  1996,  D&PL China  formed  with  parties in Hebei
Province,  one of the major cotton producing regions in the People's Republic of
China,  Hebei Ji Dai  Cottonseed  Technology  Company Ltd.  ("Ji Dai"),  a joint
venture controlled by D&PL China. In June 1997, Ji Dai commenced construction of
a cottonseed conditioning and storage facility in Shijiazhuang,  Hebei Province,
China,  under  terms  of the  joint  venture  agreement.  The new  facility  was
completed in December 1997 and seed processing and sales commenced in 1998.

In December 1997,  D&M  International,  LLC,  formed a joint venture with Ciagro
S.R.L.  ("Ciagro"), a distributor of agricultural inputs in the Argentine cotton
region,  for the  production and sale of genetically  improved  cottonseed.  CDM
Mandiyu S.R.L., is owned 60% by D&M  International,  LLC, and 40% by Ciagro. The
cotton  region,  primarily  comprised of the  Provinces  of Chaco,  Santiago del
Estero,  Salta and Jujuy,  presently has 1.2 million  acres of cotton  requiring
9,000  tons of  cotton  planting  seed per year.  CDM  Mandiyu  S.R.L.  has been
licensed to sell D&PL  cotton  varieties  containing  Monsanto's  Bollgard  gene
technology.  Sales of such varieties commenced in 1999. Future plans include the
production and sale of Roundup Ready  cottonseed  varieties  pending  government
approval.

In July 1998,  D&PL China and the Anhui  Provincial  Seed  Corporation  formed a
joint  venture,  Anhui An Dai Cotton Seed  Technology  Company,  Ltd. ("An Dai")
which is located in Hefei City,  Anhui Province,  China.  Under the terms of the
joint venture  agreement,  the newly formed  entity will produce,  condition and
sell acid  delinted  D&PL  varieties  of  cottonseed  which  contain  Monsanto's
Bollgard gene. In the fall of 1998, An Dai harvested  sufficient  seed from seed
plots in Anhui to plant up to 250,000  acres.  The joint venture did not receive
authority  to operate from the Chinese  government  until after the 1999 selling
season was completed.  Therefore,  commercial  sales are expected to commence in
early 2000.

In November 1998, D&M International LLC and Maeda  Administracao e Participacoes
Ltda, an affiliate of Agropem - Agro Pecuria Maeda S.A.,  formed a joint venture
in Minas Gerais,  Brazil. The new company,  MDM Maeda Deltapine Monsanto Algodao
Ltda., will produce,  condition and sell  acid-delinted D&PL varieties of cotton
planting  seed.  The new company  produced and  delinted  enough  cottonseed  of
conventional  varieties in 1999 to plant up to 900,000  acres.  The newly formed
company  will  introduce  transgenic  cottonseed  varieties,  both  Bollgard and
Roundup  Ready,  to the  Brazilian  market  as  soon  government  approvals  are
obtained.

Subsidiaries

The  Company's  delinting  plants in  Groblersdal,  South Africa and  Catamarca,
Argentina process foundation seed grown in these countries.  The use of Southern
Hemisphere  winter  nurseries  and seed  production  programs  such as these can
accelerate the introduction of new varieties because D&PL can raise at least two
crops per year by taking  advantage of the Southern  Hemisphere  growing season.
The  Company  maintains  a  winter  nursery  in  Costa  Rica  and  is  currently
constructing a delinting  plant there to process  foundation  seed for export to
the United States.  Multiple  winter  nursery  locations are used to manage seed
production risks.

Deltapine  Australia  Pty. Ltd., a wholly owned  Australian  subsidiary of DPLC,
conducts  breeding,  production,  conditioning  and marketing of cotton planting
seed in Australia.  Certain varieties developed in Australia are well adapted to
other Southern  Hemisphere cotton producing  countries and Australian  developed
varieties  are  exported  to  these  areas.  The  Company  sells  seed  of  both
conventional  and transgenic  varieties in Australia.  The Company,  through its
Australian  operations,  is identifying smaller potential export markets for the
Company's products throughout  Southeast Asia. The adaptability of the Company's
germplasm must be evaluated in the target markets before such sales can be made.
The recent  instability of the economies in some of the countries in this region
will make successful market development difficult.

Employees

As of February 29, 2000, the Company employed a total of 558 full time employees
worldwide.  Due to the nature of the  business,  the Company  utilizes  seasonal
employees in its delinting plants and its research and foundation seed programs.
The maximum number of seasonal  employees  approximates 300 and typically occurs
in October  and  November  of each year.  The  Company  considers  its  employee
relations to be good.

Acquisitions

In 1996, D&PL acquired Ellis Brothers Seed, Inc., Arizona  Processing,  Inc. and
Mississippi  Seed,  Inc.,  which own the  outstanding  common stock of Sure Grow
Seed,  Inc.,  (the  "Sure  Grow  Companies")  in  exchange  for stock  valued at
approximately  $70 million on the day of  closing.  D&PL  exchanged  2.8 million
shares of its common stock (after all stock splits) for all  outstanding  shares
of the three companies.  The merger was accounted for as a pooling-of-interests.
The Company  continues to market upland picker  cottonseed  varieties  under the
Sure Grow brand. Additionally, the Sure Grow breeding program has full access to
Monsanto's Bollgard and Roundup Ready gene technologies.

In 1996, the Company acquired Hartz Cotton,  Inc. from Monsanto,  which included
inventories of cotton planting seed of Hartz upland picker varieties, germplasm,
breeding stocks,  trademarks,  trade names and other assets,  for  approximately
$6.0 million.  The consideration  consisted primarily of 1,066,667 shares (after
all stock splits) of the Company's  Series M  Convertible  Non-Voting  Preferred
Stock.

In 1994,  D&PL acquired the Paymaster and Lankart cotton  planting seed business
("Paymaster"),   for  approximately   $14.0  million.   Since  the  1940's,  the
Paymaster(R)  and  Lankart(R)  upland  stripper  cottonseed  varieties have been
developed  for and  marketed  primarily in the High Plains of Texas and Oklahoma
(the  "High   Plains").   Although  the  Paymaster   varieties  are  planted  on
approximately  80% of the estimated 4.0 to 5.0 million  cotton acres in the High
Plains, only a portion of that seed is actually sold by Paymaster.  Farmer-saved
seed accounts for a significant  portion of the seed needed to plant the acreage
in this  market  area.  Prior to 1997,  the seed  needed to plant the  remaining
acreage was sold by Paymaster  and its 12 sales  associates  through a certified
seed  program.  Under this program,  Paymaster  sold parent seed to its contract
growers who  planted,  produced  and  harvested  the progeny of the parent seed,
which Paymaster then purchased from the growers.  The progeny of the parent seed
was  then  sold by  Paymaster  to the  sales  associates  who in turn  delinted,
conditioned,  bagged  and  sold  it to  others  as  certified  seed.  The  sales
associates  paid a royalty to Paymaster on  certified  seed sales.  Beginning in
fiscal 1997, the certified  seed program was  discontinued  and the Company,  in
addition to producing parent seed, commenced delinting, conditioning and bagging
finished  seed.  Unconditioned  seed is also  supplied  by D&PL to two  contract
processors  who delint,  condition and bag seed for a fee. This finished seed is
sold by Paymaster to distributors and dealers.

The Company acquired, in 1994, from the Supima Association of America ("Supima")
certain  planting seed inventory,  the right to use the Supima(R) trade name and
trademark  and the right to distribute  Pima  extra-long  staple  (fiber-length)
cotton varieties. D&PL also entered into a research agreement with a third party
to develop Pima  varieties  that allows D&PL the right of first  refusal for any
Pima varieties developed under this program. Pima seed is produced,  conditioned
and sold by D&PL to distributors and dealers.

Biotechnology

Collaborative  biotechnology  licensing  agreements,  which were  executed  with
Monsanto  in 1992 and  subsequently  revised in 1993 and 1996,  provide  for the
commercialization of Monsanto's Bollgard ("Bacillus thuringiensis" or "Bt") gene
technology in D&PL's  varieties.  The selected Bt is a bacterium found naturally
in soil  and  produces  proteins  toxic  to  certain  lepidopteran  larvae,  the
principal  cotton  pests  in many  cotton  growing  areas.  Monsanto  created  a
transgenic  cotton plant by inserting  Bt genes into cotton plant  tissue.  This
transgenic  plant tissue is lethal to certain  lepidopteran  larvae that consume
it. The gene and related  technology  were  patented or licensed  from others by
Monsanto  and were  licensed to D&PL for use under the trade name  Bollgard.  In
D&PL's  primary  markets,  the  cost  of  insecticides  is  the  largest  single
expenditure  for many  cotton  growers.  The insect  resistant  capabilities  of
transgenic  cotton  containing  the  Bollgard  gene may  reduce  the  amount  of
insecticide  required  to be  applied  by cotton  growers  using  planting  seed
containing  the Bollgard  gene. In October 1995,  Monsanto was notified that the
United States Environmental  Protection Agency ("EPA") had completed its initial
registration  of the  Bollgard  gene  technology,  thus  clearing  the  way  for
commercial  sales of seed  containing  the  Bollgard  gene.  In 1996,  D&PL sold
commercially  for the first time two Deltapine  varieties,  which  contained the
Bollgard  gene,  in  accordance  with the terms of the Bollgard Gene License and
Seed  Services  Agreement  (the  "Bollgard  Agreement")  between the Company and
Monsanto.  This initial EPA  registration  expires on January 1, 2001,  at which
time the EPA will,  among other  things,  reevaluate  the  effectiveness  of the
insect resistance management plan and decide whether to convert the registration
to a non-expiring (and/or unconditional) registration.

Pursuant to the terms of the Bollgard Agreement,  farmers must buy a limited use
sublicense  for the  technology  from D&M Partners,  a  partnership  of D&PL and
Monsanto, in order to purchase seed containing the Bollgard gene technology. The
distributor/dealers  who  coordinate  the  farmer  licensing  process  receive a
service payment not to exceed 20% of the technology  sublicensing fee. After the
dealers and distributors  are compensated,  D&M Partners pays Monsanto a royalty
equal  to 71% of the net  sublicense  fee  (technology  sublicensing  fees  less
distributor/dealer  payments) and D&PL retains 29% for its services. The license
agreement  continues  until the later of the  expiration of all patent rights or
October 2008. D&M Partners  contracts the billing and collection  activities for
Bollgard and Roundup Ready licensing fees to Monsanto.

Pursuant to the Bollgard  Agreement,  Monsanto  must defend and  indemnify  D&PL
against claims of patent infringement,  including all damages awarded or amounts
paid in  settlements.  Monsanto  must also  indemnify  D&PL  against a) costs of
inventory and b) lost profits on inventory which becomes  unsaleable  because of
patent  infringement  claims.  Monsanto  must  defend  any  claims of failure of
performance of a Bollgard gene.  Monsanto and D&PL share the cost of any product
performance claims in proportion to each party's share of the royalty. Indemnity
from Monsanto only covers performance claims involving failure of performance of
the Bollgard gene and not claims arising from other causes.

D&PL has also  developed  transgenic  cotton  varieties  that  are  tolerant  to
Roundup,  a glyphosate-based  herbicide sold by Monsanto.  In 1996, such Roundup
Ready plants were approved by the Food and Drug  Administration,  the USDA,  and
the EPA. In February 1996,  the Company and Monsanto  executed the Roundup Ready
Gene License and Seed Services  Agreement (the "Roundup Ready  Agreement") which
provides for the  commercialization  of Roundup  Ready  cottonseed.  The Roundup
Ready Agreement grants a license to D&PL and certain of its affiliates the right
in the  United  States to sell  cottonseed  of  D&PL's  varieties  that  contain
Monsanto's  Roundup  Ready gene.  The  Roundup  Ready gene makes  cotton  plants
tolerant to contact with Roundup herbicide.  Similar to the Bollgard  Agreement,
farmers  must  execute  limited  use  sublicenses  in  order  to  purchase  seed
containing the Roundup Ready Gene. The  distributors/dealers  who coordinate the
farmer licensing  process receive a portion of the technology  sublicensing fee.
D&PL's  portion of the Roundup  Ready  technology  fee varies  depending  on the
technology fee per acre established by Monsanto.  In 1998 and 1999, D&M Partners
paid Monsanto  approximately  70% of the Roundup Ready  technology fees and D&PL
retained the remaining 30%.

Pursuant to the Roundup Ready Agreement, Monsanto must defend and indemnify D&PL
against claims of patent infringement,  including all damages awarded or amounts
paid in  settlements.  Monsanto  will also  indemnify  D&PL  against the cost of
inventory that becomes  unsaleable  because of patent  infringement  claims, but
Monsanto  is not  required  to  indemnify  D&PL  against  lost  profits  on such
unsaleable  seed.  In contrast  with the Bollgard Gene License where the cost of
gene  performance  claims  will be  shared  in  proportion  to the  division  of
sublicense  revenue,  Monsanto  must  defend  and must bear the full cost of any
claims of failure of performance of the Roundup Ready Gene. In both  agreements,
generally,  D&PL  is  responsible  for  varietal/seed  performance  issues,  and
Monsanto is responsible for failure of the genes.

In 2000, the Company has for sale for either commercial or experimental purposes
16 cotton planting seed varieties that contain the Bollgard gene technology,  20
cotton  planting seed varieties that contain the Roundup Ready gene  technology,
21 varieties that contain both technologies, and 50 conventional varieties.

In February  1997,  the Company and Monsanto  executed the Roundup Ready Soybean
License Agreement (the "Roundup Ready Soybean Agreement") which provides for the
commercialization  of Roundup Ready soybean seed and has  provisions  similar to
the Roundup Ready Agreement for cottonseed.

On July 27, 1999,  United States  Patent No.  5,929,300 was issued to the United
States of America as represented by the Secretary of Agriculture (USDA) entitled
POLLEN BASED  TRANSFORMATION  SYSTEM  USING SOLID  MEDIA.  D&PL has an option to
obtain a license for pollen  transformation,  subject to certain rights reserved
to the USDA. D&PL has notified the USDA of its intention to exercise its rights.
The patent covers transformation of plants.

In March 1998,  D&PL was granted  United States Patent No.  5,723,765,  entitled
CONTROL OF PLANT GENE  EXPRESSION.  This patent is owned jointly by D&PL and the
United States of America,  as represented by the Secretary of  Agriculture.  The
patent broadly covers plants and seed, both transgenic and conventional,  of all
species for a system designed to allow control of progeny seed viability without
harming  the  crop.  One  application  of the  technology  could  be to  control
unauthorized  planting of seed of proprietary varieties (sometimes called "brown
bagging") by making such practice  non-economic  since  unauthorized  saved seed
will not  germinate,  and would be  useless  for  planting.  The  patent has the
prospect of opening significant worldwide seed markets to the sale of transgenic
technology in varietal  crops in which crop seed  currently is saved and used in
subsequent  seasons as planting seed.  D&PL has stated it intends that licensing
of this technology will be made widely available to other seed companies.

Both patents were  developed  from a research  program  conducted  pursuant to a
Cooperative  Research  and  Development  Agreement  between  D&PL  and the  U.S.
Department of Agriculture's Agricultural Research Service in Lubbock, Texas. The
technologies  resulted from basic research and will require further development,
which is already  underway,  in order to be used in commercial seed. The Company
estimates  that it will be several  years  before  these  technologies  could be
available commercially.

Since  1987,  D&PL has  conducted  research  using  genes  provided by DuPont to
develop  soybean plants that are tolerant to certain  DuPont ALS(R)  herbicides.
Such plants enable farmers to apply these  herbicides  for weed control  without
significantly affecting the agronomics of the soybean plants. Since soybean seed
containing the ALS herbicide-tolerant trait was not genetically engineered, sale
of this seed does not require  government  approval,  although the  herbicide to
which they express tolerance must be EPA approved.

The Company has license, research and development,  confidentiality and material
transfer  agreements with providers of technology that the Company is evaluating
for potential  commercial  applications  and/or  introduction.  The Company also
contracts  with third parties to perform  research on the  Company's  behalf for
enabling  and  other  technologies  that the  Company  believes  have  potential
commercial applications in varietal crops around the world.

Commercial Seed

Seed of all commercial plant species is either varietal or hybrid. D&PL's cotton
and soybean seed are  varietals.  Varietal  plants can be  reproduced  from seed
produced by a parent  plant,  with the offspring  exhibiting  only minor genetic
variations.  The Plant  Variety  Protection  Act of 1970, as amended in 1994, in
essence prohibits,  with limited  exceptions,  purchasers of varieties protected
under the amended Act from selling seed harvested from these  varieties  without
permission  of the plant  variety  protection  certificate  owner.  Some foreign
countries provide similar legal protection for breeders of crop varieties.

Although  cotton is varietal  and,  therefore,  can be grown from seed of parent
plants saved by the growers,  most farmers in D&PL's  primary  domestic  markets
purchase seed from commercial  sources each season because  cottonseed  requires
delinting  prior to seed  treatment  with  chemicals  and in order to be sown by
modern planting  equipment.  Delinting and  conditioning may be done either by a
seed company on its  proprietary  seed or by independent  delinters for farmers.
Modern  cotton  farmers in upland picker areas  generally  recognize the greater
assurance of genetic purity,  quality and convenience that professionally  grown
and  conditioned  seed offers  compared  to seed they might save.  Additionally,
Federal patent law makes unlawful any  unauthorized  planting of seed containing
patented genetic technology saved from prior crops.

In connection with its seed operations,  the Company farms  approximately  2,600
acres in the U.S.,  primarily for research purposes and for production of cotton
and soybean  foundation  seed.  The Company has annual  agreements  with various
growers to produce seed for cotton and  soybeans.  The growers plant parent seed
purchased from the Company and follow quality assurance  procedures required for
seed production.  If the grower adheres to established Company quality assurance
standards  throughout the growing season and if the seed meets Company standards
upon  harvest,  the  Company may be  obligated  to  purchase  specified  minimum
quantities of seed,  usually in its first and second fiscal quarters,  at prices
equal to the  commodity  market  price of the seed  plus a grower  premium.  The
Company then conditions the seed for sale.

The  majority of the  Company's  sales are made from early in the second  fiscal
quarter  through the beginning of the fourth fiscal  quarter.  Varying  climatic
conditions can change the quarter in which seed is delivered,  thereby  shifting
sales and the  Company's  earnings  between  quarters.  Thus,  seed  production,
distribution  and sales are seasonal and interim results will not necessarily be
indicative of the Company's results for a fiscal year.

Revenues from domestic seed sales are generally recognized when seed is shipped.
Revenues from Bollgard and Roundup Ready licensing fees are recognized  based on
the  number  of acres  expected  to be  planted  with such seed when the seed is
shipped.  Prior to 1998,  licensing  fees were based on the estimated  number of
acres that farmers represented would be planted with the seed purchased. In 1998
and 1999,  the  licensing  fee charged to farmers  was based on  pre-established
planting  rates for seven  geographic  regions and the estimated  number of seed
contained  in each bag  which may vary by  variety,  location  grown,  and other
factors.  Revenue is recognized based on the established technology fee per unit
shipped to each geographic region. Domestically, the Company promotes its cotton
and soybean seed directly to farmers and sells its seed through distributors and
dealers.  All of the Company's  domestic seed products  (including  Bollgard and
Roundup  Ready  technologies)  are subject to return or credit,  which vary from
year to year.  The  annual  level of  returns  and,  ultimately,  net  sales are
influenced  by  various  factors,   principally  commodity  prices  and  weather
conditions  occurring in the spring  planting  season during the Company's third
and fourth quarters.  The Company provides for estimated returns as sales occur.
To the extent actual returns differ from estimates, adjustments to the Company's
operating results are recorded when such differences become known,  typically in
the Company's fourth quarter. All significant returns occur or are accounted for
by fiscal year end.  International export revenues are recognized upon the later
of when seed is shipped or the date letters of credit are confirmed.  Generally,
international  export sales are not subject to return.  All other  international
revenues from the sale of planting seed,  less  estimated  reserves for returns,
are recognized when the seed is shipped.

Euro Currency Conversion

On January 1, 1999,  the euro became the common  legal  currency of 11 of the 15
member  countries  of the  European  Union.  On  that  date,  the  participating
countries fixed  conversion  rates between their sovereign  currencies  ("legacy
currencies")  and the euro.  On  January  4,  1999,  the euro  began  trading on
currency  exchanges and became available for non-cash  transactions.  The legacy
currencies will remain legal tender through December 31, 2001. Beginning January
2, 2002,  euro-denominated  bills and coins will be  introduced,  and by July 1,
2002,  legacy  currencies will no longer be legal tender.  To date, D&PL has not
been affected by the euro currency conversion.

Year 2000 Readiness Disclosure

Beginning in 1996,  D&PL  initiated  its Global Year 2000 program to ensure that
its infrastructure and information systems comply with the systems  requirements
for the  year  2000.  D&PL  has  essentially  completed  the  program.  Based on
available  knowledge,  the  majority of  systems,  including  critical  business
systems,  comply  with  year  2000  requirements,  due  in  large  part  to  the
installation  in fiscal 1997 of a third party software  system that is year 2000
compliant, at a cost in excess of $3.0 million. Contingency plans were developed
for all critical  vendor  products and services.  These plans identify  critical
functions,  acceptable delay times and business resumption strategies. The major
task remaining is completion of the  implementation of the Desktop  Redeployment
Plan. The Company  continues to evaluate the estimated costs associated with the
year 2000  compliance  based on actual  experience.  While the year 2000 efforts
involve additional costs, D&PL believes, based on available information, that it
will be able to manage its  in-house  year 2000  transition  issues  without any
material adverse effect on its business operations or financial position.  Total
cost  incurred  to date for year  2000  considerations  (excluding  third  party
software)  approximate  $600,000 and the Company  estimates  that no  additional
funds are required to complete the year 2000 compliance process.

D&PL also has  contacted  its major  suppliers  and  customers  to assess  their
preparations  for the year 2000.  These  actions are taken to help  mitigate the
possible external impact of year 2000 issues. It is not feasible to fully assess
the  potential  consequences  if D&PL's  customers are not  compliant.  D&PL has
developed  business  continuity  plans to minimize  the impact of such  external
events.  D&M Partners (a  partnership  of which D&PL owns 90% and Monsanto  owns
10%) contracts with Monsanto to 1) administer  sublicensing to farmers the right
to  use  the  Bollgard  and  Roundup  Ready  technologies,   2)  bill  for  such
technologies and 3) collect the sublicensing  revenues for using technology.  In
its 1998 Annual Report,  Monsanto  disclosed that all year 2000 remediation work
for its internal  systems  would be completed by the third  calendar  quarter of
1999. The Company is not able to predict at the present time the impact, if any,
on its business if Monsanto is unable to resolve any remaining year 2000 issues.

D&PL's  discussion  of the year 2000  computer  issue  contains  forward-looking
information.   D&PL  believes  that  its  critical  computer  systems  are  year
2000-compliant.  Nevertheless, factors that could cause actual results to differ
from the Company's  expectations  include the successful  implementation of year
2000 initiatives by its customers and suppliers, changes in the availability and
cost of  resources  to  implement  year 2000  changes,  and  D&PL's  ability  to
successfully identify and correct all systems affected by the year 2000 issue.

Outlook

From time to time, the Company may make  forward-looking  statements relating to
such matters as anticipated financial performance,  existing products, technical
developments,  new  products,  research and  development  activities,  year 2000
issues and similar matters. The Private Securities Litigation Reform Act of 1995
provides a safe harbor for forward-looking  statements.  In order to comply with
the terms of the safe harbor,  the Company notes that a variety of factors could
cause the Company's actual results and experience to differ  materially from the
anticipated   results  or  other   expectations   expressed  in  the   Company's
forward-looking  statements.  The risks and  uncertainties  that may  affect the
operations,  performance,  development  and  results of the  Company's  business
include those noted elsewhere in this Item and the following:

      On December 20, 1999, Monsanto withdrew its  pre-notification  filed under
the HSR Act thereby abandoning their efforts to consummate the merger.

      Monsanto's  failure  to  complete  the  merger  with  Monsanto  may have a
material effect on the Company. However, such effect is not known at this time.

      Demand  for  D&PL's  seed will be  affected  by  government  programs  and
      policies  and  most  importantly,  by  weather.  Demand  for  seed is also
      influenced by commodity  prices and the demand for a crop's  end-uses such
      as textiles, animal feed, food and raw materials for industrial use. These
      factors,  along with weather,  influence the cost and availability of seed
      for subsequent seasons.  Weather impacts crop yields, commodity prices and
      the planting  decisions that farmers make regarding both original planting
      commitments and, when necessary, replanting levels.

      The planting seed market is highly  competitive,  and D&PL  varieties face
      competition  from  a  number  of  seed  companies,   diversified  chemical
      companies, agricultural biotechnology companies, governmental agencies and
      academic   and   scientific   institutions.   A  number  of  chemical  and
      biotechnology   companies  have  seed   production   and/or   distribution
      capabilities  to  ensure  market  access  for new  seed  products  and new
      technologies  that may compete with the  Bollgard  and Roundup  Ready gene
      technologies.  The  Company's  seed  products and  technologies  contained
      therein may encounter substantial  competition from technological advances
      by others or  products  from new market  entrants.  Many of the  Company's
      competitors are, or are affiliated with, large diversified  companies that
      have substantially greater resources than the Company.

      The production, distribution or sale of crop seed in or to foreign markets
      may be  subject  to  special  risks,  including  fluctuations  in  foreign
      currency, exchange rate controls, expropriation, nationalization and other
      agricultural,   economic,   tax  and   regulatory   policies   of  foreign
      governments.  Particular  policies  which  may  affect  the  domestic  and
      international  operations of D&PL include the use of and the acceptance of
      products that were produced  from plants that were  genetically  modified,
      the testing,  quarantine and other restrictions relating to the import and
      export of plants and seed products and the  availability (or lack thereof)
      of proprietary  protection for plant products. In addition,  United States
      government  policies,  particularly  those  affecting  foreign  trade  and
      investment, may impact the Company's international operations.

      The recent publicity related to genetically  modified organisms  ("GMO's")
      or products  made from plants that contain GMO's may have an effect on the
      Company's sales in the future. In 1999, approximately 80% of the Company's
      cotton seed that was sold contained either the Bollgard, Roundup Ready, or
      both  gene  technologies  and  64% of the  Company's  soybean  seed  sales
      contained  the Roundup Ready gene  technology.  Although many farmers have
      rapidly  adopted  these  technologies,  the alleged  concern over finished
      products that contain GMO's could impact demand for crops raised from seed
      containing such traits.

      Due to the varying levels of  agricultural  and social  development of the
      international markets in which the Company operates and because of factors
      within the  particular  international  markets  targeted  by the  Company,
      international  profitability and growth may be less stable and predictable
      than domestic profitability and growth.

      Overall  profitability  will depend on the factors  noted above as well as
      weather conditions, government policies in all countries where the Company
      sells products and operates,  worldwide  commodity  prices,  the Company's
      ability to  successfully  open new  international  markets,  the Company's
      ability  to  successfully  continue  the  development  of the High  Plains
      market,  the  technology  partners'  ability to obtain  timely  government
      approval  (and maintain  such  approval)  for existing and for  additional
      biotechnology  products  on which they and the Company are working and the
      Company's  ability to produce  sufficient  commercial  quantities  of high
      quality  planting  seed of these  products.  Any delay in or  inability to
      successfully complete these projects may affect future profitability.

Item 6.  Exhibits and Reports on Form 8-K

 (a) Exhibits.

    11.01 Computation of Earnings Per Share

    27.01 Financial Data Schedule

(b) Reports on Form 8-K.

      No reports on Form 8-K were filed  during the quarter  ended  February 29,
2000.

<PAGE>

                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                                     DELTA AND PINE LAND COMPANY


Date:     April 14, 2000                             /s/ Roger D. Malkin
                                                     ---------------------------
                                                     Roger D. Malkin, Chairman
                                                     and Chief Executive Officer

Date:     April 14, 2000                             /s/ W. Thomas Jagodinski
                                                     ---------------------------
                                                     W. Thomas Jagodinski,
                                                     Vice President - Finance
                                                        and Treasurer


<PAGE>


                                  EXHIBIT 11.01

                        COMPUTATION OF EARNINGS PER SHARE
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>

                                                                                FOR THE SIX MONTHS ENDED
                                                                                ------------------------
                                                                             February 28,      February 29,
                                                                                 1999              2000
                                                                           ----------------- -----------------
<S>                                                                                     <C>                <C>
BASIC EARNINGS PER SHARE:

WEIGHTED AVERAGE NUMBER OF SHARES OF
   COMMON STOCK OUTSTANDING                                                ----------------- -----------------
   DURING THE PERIOD                                                                 38,397            38,653
                                                                           ================= =================
NET INCOME/(LOSS) BEFORE CUMULATIVE EFFECT OF
   ACCOUNTING CHANGE APPLICABLE TO COMMON STOCKHOLDERS                          $   (4,080)        $   52,020
CUMULATIVE EFFECT OF ACCOUNTING CHANGE                                                   -             (2,965)
                                                                           ----------------- -----------------
NET INCOME/(LOSS) APPLICABLE TO COMMON SHARES                                   $   (4,080)        $   49,055
                                                                           ================= =================
   BASIC EARNINGS PER SHARE                                                     $    (0.11)         $    1.27
                                                                           ================= =================

DILUTED EARNINGS PER SHARE:


WEIGHTED AVERAGE NUMBER OF SHARES                                                    38,397            38,653
    OF COMMON STOCK OUTSTANDING
    DURING THE PERIOD
WEIGHTED AVERAGE OF SHARES ATTRIBUTED TO
   CONVERTIBLE PREFERRED STOCK                                                       -  (a)             1,066
NUMBER OF SHARES ATTRIBUTED TO STOCK OPTIONS                                         -  (a)               467
WEIGHTED AVERAGE NUMBER OF SHARES
   OF COMMON STOCK OUTSTANDING
   DURING THE PERIOD FOR COMPUTATION                                       ----------------- -----------------
   OF DILUTED EARNINGS PER SHARE                                                     38,397            40,186
                                                                           ================= =================

NET INCOME/(LOSS) BEFORE CUMULATIVE EFFECT OF
   ACCOUNTING CHANGE APPLICABLE TO COMMON STOCKHOLDERS                          $    (4,080)       $   52,028
CUMULATIVE EFFECT OF ACCOUNTING CHANGE
                                                                                          -            (2,965)
                                                                           ----------------- -----------------

   NET INCOME/(LOSS)                                                            $    (4,080)       $   49,055
                                                                           ================= =================
   DILUTED EARNINGS PER SHARE                                                   $     (0.11)       $     1.22
                                                                           ================= =================

</TABLE>

(a)  Inclusion of shares would be anti-dilutive.


<PAGE>


                                  EXHIBIT 11.01 (continued)

                        COMPUTATION OF EARNINGS PER SHARE
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>

                                                                                FOR THE THREE MONTHS ENDED
                                                                                --------------------------
                                                                           February , 1999      February ,
                                                                                                   2000

                                                                           ----------------- -----------------
<S>                                                                                     <C>                <C>
BASIC EARNINGS PER SHARE:

WEIGHTED AVERAGE NUMBER OF SHARES OF
   COMMON STOCK OUTSTANDING                                                ----------------- -----------------
   DURING THE PERIOD                                                                 38,422            38,644
                                                                           ================= =================

NET INCOME BEFORE CUMULATIVE EFFECT OF ACCOUNTING CHANGE
   APPLICABLE TO COMMON STOCKHOLDERS                                              $   2,382        $   58,595
CUMULATIVE EFFECT OF ACCOUNTING CHANGE
                                                                                          -                 -
                                                                           ----------------- -----------------
NET INCOME                                                                        $   2,382        $   58,595
                                                                           ================= =================
   BASIC EARNINGS PER SHARE                                                       $    0.06         $    1.52
                                                                           ================= =================

DILUTED EARNINGS PER SHARE:


WEIGHTED AVERAGE NUMBER OF SHARES                                                    38,422            38,644
    OF COMMON STOCK OUTSTANDING
    DURING THE PERIOD
WEIGHTED AVERAGE NUMBER OF SHARES ATTRIBUTABLE
    TO CONVERTIBLE PREFERRED STOCK                                                    1,066             1,066
NUMBER OF SHARES ATTRIBUTABLE TO STOCK OPTIONS                                        1,331               400
WEIGHTED AVERAGE NUMBER OF SHARES
   OF COMMON STOCK OUTSTANDING
   DURING THE PERIOD FOR COMPUTATION                                       ----------------- -----------------
   OF DILUTED EARNINGS PER SHARE                                                     40,819            40,110
                                                                           ================= =================

NET INCOME BEFORE CUMULATIVE EFFECT OF ACCOUNTING CHANGE
   APPLICABLE TO COMMON STOCKHOLDERS                                              $   2,382        $   58,595
CUMULATIVE EFFECT OF ACCOUNTING CHANGE
                                                                                          -                 -
                                                                           ----------------- -----------------

   NET INCOME                                                                     $   2,406        $   58,635
                                                                           ================= =================
   DILUTED EARNINGS PER SHARE                                                     $    0.06         $    1.46
                                                                           ================= =================
</TABLE>

<TABLE> <S> <C>


<ARTICLE>                                                                      5
<CIK>                                                                 0000902277
<NAME>                                               Delta and Pine Land Company
<MULTIPLIER>                                                               1,000


<S>                                                                          <C>

<PERIOD-TYPE>                                                              3-MOS
<FISCAL-YEAR-END>                                                    AUG-31-2000
<PERIOD-START>                                                       SEP-01-1999
<PERIOD-END>                                                         FEB-29-2000
<CASH>                                                                    17,345
<SECURITIES>                                                                   0
<RECEIVABLES>                                                            127,774
<ALLOWANCES>                                                                 160
<INVENTORY>                                                               74,118
<CURRENT-ASSETS>                                                         233,615
<PP&E>                                                                    99,379
<DEPRECIATION>                                                            34,735
<TOTAL-ASSETS>                                                           310,402
<CURRENT-LIABILITIES>                                                    163,329
<BONDS>                                                                        0
                                                          0
                                                                  107
<COMMON>                                                                   3,883
<OTHER-SE>                                                               128,485
<TOTAL-LIABILITY-AND-EQUITY>                                             310,402
<SALES>                                                                  108,751
<TOTAL-REVENUES>                                                         108,751
<CGS>                                                                     77,410
<TOTAL-COSTS>                                                           (51,944)
<OTHER-EXPENSES>                                                           (237)
<LOSS-PROVISION>                                                               0
<INTEREST-EXPENSE>                                                           188
<INCOME-PRETAX>                                                           83,334
<INCOME-TAX>                                                              31,250
<INCOME-CONTINUING>                                                       52,084
<DISCONTINUED>                                                                 0
<EXTRAORDINARY>                                                                0
<CHANGES>                                                                (2,965)
<NET-INCOME>                                                              49,119
<EPS-BASIC>                                                                 1.27
<EPS-DILUTED>                                                               1.22



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission